Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
reconcile timing | compare the actual administration and collection records | Work with nursing to reconcile timing before labeling the concentration. | Plan | Monitoring actions, escalation and result communication |
relative bioavailability | systemic availability of one preparation compared with a reference preparation | The formulation comparison reports relative bioavailability. | Assessment | Drug concentrations, exposure and assay interpretation |
reporting limit | boundary beyond which the laboratory uses a qualified result | The value is below the reporting limit and is retained with its inequality sign. | Assessment | Drug concentrations, exposure and assay interpretation |
residual error | difference or unexplained variation between observed and model-predicted values | The model review examined residual error across early and late samples. | Assessment | Drug concentrations, exposure and assay interpretation |
salicylate | analyte measured in evaluation of salicylate exposure | Two salicylate concentrations are listed with their individual collection times. | Objective | Drug levels - named analytes and exposure reports |
specimen carryover | residual material from another sample affects a measurement | The laboratory investigated possible specimen carryover after the unexpected result. | Assessment | Drug concentrations, exposure and assay interpretation |
supratherapeutic | above the intended treatment range | The concentration was supratherapeutic for the stated target. | Assessment | Medication response and safety |
symptom correlation | linking a reported symptom to a measurement or exposure over time | Review the diary for symptom correlation with the concentration changes. | Plan | Monitoring actions, escalation and result communication |
systemic clearance | volume of plasma effectively cleared of drug per unit time | The exposure estimate assumes that systemic clearance remained stable over the interval. | Assessment | Drug concentrations, exposure and assay interpretation |
therapeutic | within the intended treatment range or having treatment effect | The measured concentration is within the stated therapeutic range. | Assessment | Medication response and safety |
total body potassium depletion | net loss of potassium from the body | Total body potassium depletion was considered despite a single serum concentration within range. | Assessment | Acid-base and electrolyte interpretation |
unbound exposure | exposure attributable to drug not bound to proteins or other constituents | The model estimates unbound exposure from the available free concentrations. | Assessment | Drug concentrations, exposure and assay interpretation |
unit of measure | scale used for a numerical result | The unit of measure on the original concentration is ng/mL. | Objective | Drug levels - analyte, specimen and reporting |
unit reconciliation | checking and aligning the units used for reported and comparison values | The interpretation awaits unit reconciliation with the original laboratory report. | Assessment | Drug concentrations, exposure and assay interpretation |
unverified administration time | time the dose was given has not been established | Unverified administration time limits how precisely the measured concentration can be timed. | Assessment | Medication response, exposure and reconciliation |
valproate | antiseizure and mood-stabilizing drug measured as total or free | The report identifies free valproate and lists the corresponding total concentration. | Objective | Drug levels - named analytes and exposure reports |
vancomycin | glycopeptide antibiotic measured for exposure monitoring in selected settings | The vancomycin report lists a measured concentration and a separate estimated AUC24. | Objective | Drug levels - named analytes and exposure reports |
| obtaining blood through a needle placed into a vein | Request peripheral venipuncture for the repeat concentration. | Plan | Specimen collection, imaging and follow-up procedures | |
voriconazole | azole antifungal with selected use of trough monitoring | The voriconazole concentration is labeled with dose route and collection time. | Objective | Drug levels - named analytes and exposure reports |
washout interval | time since discontinuation before the specified assessment | The washout interval is recorded alongside the residual concentration. | Objective | Drug levels - collection and dose timing |
Y-site coadministration | two solutions meet at a shared connection before reaching the patient | Y-site coadministration was documented with the actual products and concentrations. | Objective | Vascular access and infusion observations |
yellow vision | yellow tint to vision reported by the patient | The patient reports brief yellow vision without a measured concentration yet. | Subjective | Medication history, adherence and level-related symptoms |